O achado de maior destaque pode ser visto no sentido da importancia de locais proximos a residencia ou ao trabalho para aquisicao de
FVL.
* Factor V Leiden: No previous testing for
FVL had been performed within the last 3 years.
In the genetic analysis, 1 (6.7%) of 15 patients evaluated for
FVL gene mutation were heterozygous, 2 (13.3%) of 15 patients evaluated for Prt G20210A gene mutation were heterozygous, 2 (13.3%) of 15 patients evaluated for MTHFR C677T gene mutation were heterozygous and 2 (13.3%) of them were homozygous; 7 (46.7%) of 15 cases evaluated for MTHFR A1298C gene mutation were heterozygous and 1 (6.7%) of them was homozygous.
In the examination of hereditary thrombophilia, the most common tests performed include antithrombin (AT), protein C (PC), protein S (PS),
FVL and PTM tests.
The search for
FVL technology is routed through the Joint Multi-Role Technology Demonstrator.
The Future Vertical Lift (
FVL) initiative was started in 2008 with a US Congressional caucus voicing concern over: "the lack of a strategic plan for improving the state of vertical lift aircraft in the United States." The ambition was to address the range of rotorcraft needs across the DOD which would involve a range of aircraft.
In PTS,
FVL mutation raises the risk of early miscarriages and early intrauterine fetal deaths [36].
Van Lanschot Bankiers N.V.'s (
FvL, BBB+/Stable/F2) EUR5bn mortgage covered bonds issued out of the bank's conditional pass-through programme at 'AAA'.
The most common cause of hereditary thrombophilia is factor V Leiden (
FVL) and prothrombin gene mutation.5 Studies have reported prevalence of
FVL mutation among women with recurrent miscarriage ranging from 3% to 42%.6
FVL prevalence in Caucasian population is 4% to 7%.7
Results: In 100 patients of Deep Vein Thrombosis (DVT), frequency of Factor V Leiden (
FVL) was 13% and it is was 2% in healthy control group.
As TH mais comuns incluem a mutacao do fator V Leiden (
FVL G1691A), a mutacao do gene da protrombina (protrombina G20210A), a deficiencia de proteina C (PCD), a deficiencia de proteina S (PSD), a mutacao da metilenotetrahidrofolato redutase (MTHFR) e a deficiencia da antitrombina III (AT).